Pfizer gets CDSCO panel marketing authorization for Infliximab Medical Dialogues Team15 Sept 2021 1:52 PM ISTNew Delhi: Granting permission for a local Phase III clinical trial waver, the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Revise Itolizumab phase 3 study protocol for Covid-19: CDSCO panel tells Biocon Medical Dialogues Team13 Sept 2021 5:26 PM ISTNew Delhi: After reviewing Biocon's Phase III trial protocol for Itolizumab for treating Covid-19 patients, the Subject Expert Committee (SEC)...
Glenmark gets CDSCO panel nod to market Remogliflozin, Vildagliptin, Metformin FDC drug Medical Dialogues Team12 Sept 2021 11:00 AM ISTNew Delhi: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has given its nod to pharma major Glenmark...
Semaglutide prescription to be restricted to endocrinologists only: CDSCO panel tells Novo Nordisk Medical Dialogues Team11 Sept 2021 4:48 PM ISTNew Delhi: In a major development, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has...
No efficacy data of Regdanvimab on COVID variants in India: CDSCO panel rejects Abbott proposal Medical Dialogues Team10 Sept 2021 5:41 PM ISTNew Delhi: In a major setback to Abbott Healthcare, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has...
Zydus Healthcare gets CDSCO panel nod for study of Indacaterol, Budesonide inhaler Medical Dialogues Team10 Sept 2021 2:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has shown a green light to Zydus...
Laurus Labs gets CDSCO panel nod to conduct BE study of cystic fibrosis FDC drug Medical Dialogues Team8 Sept 2021 1:59 PM ISTNew Delhi: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has granted permission to Laurus Labs to...
Cipla gets CDSCO panel nod for BE study of idiopathic pulmonary fibrosis drug Pirfenidone Medical Dialogues Team7 Sept 2021 2:59 PM ISTNew Delhi: Pharmaceutical major, Cipla has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization...
Conduct phase 3 trail of Esomeprazole Gastro-resistant Tablets: CDSCO panel tells Sun Pharma Medical Dialogues Team30 Aug 2021 3:36 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Organization (CDSCO) has recommended Sun Pharma to conduct a...
Dr Reddys Minoxidil gets CDSCO panel nod to treat androgenic alopecia in females Medical Dialogues Team23 Aug 2021 4:51 PM ISTNew Delhi: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has given its nod to pharma major Dr Reddy's...
Conduct phase 3 trial of plaque psoriasis FDC drug on Indian patients: CDSCO panel tells Glenmark Medical Dialogues Team22 Aug 2021 11:30 AM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Organization (CDSCO) has recommended Glenmark Pharmaceuticals...
Johnson and Johnson Rilematovir gets CDSCO panel okay for phase 3 trial Medical Dialogues Team18 Aug 2021 4:18 PM ISTNew Delhi: Global pharmaceuticals major Johnson and Johnson (JnJ) has got a go ahead from the Subject Expert Committee (SEC) of the Central Drugs...
